Pharmaceutical & BioScience Society, PBSS

Symposium

[Free Online Symposium] Artificial Intelligence and Machine Learning to Drive Therapeutic Drug Discovery

Speakers: Abraham Heifets (Atomwise); Tom Miller (Entos AI); Fio Ruggiu (Insitro); Wayne Tang & Sathesh Bhat (Schrodinger); Alex Zhavoronkov (Insilico); Vijay Shahani (Cyclica); Brandon Allgood (Valo Health)
Organizers: Kevin McLure (Ermaris Bio) and Leping Li (Haihe Biopharma)
Date: 2021-11-17- 11/18/2021
Time: 8:30-13:00 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor: (1)Applied Biomath;(Major Sponsorship - Day 1 still open)
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2021-11-15 (it will close sooner if the seating cap is reached)

About the Topic

Day 1: November 17

PST	EST	Topic	Presenter
8:30am - 8:45am	11:30am- 11:45am	Welcome Remarks	Kevin McLure (Ermaris Bio)
8:45am - 9:30am	11:45am- 12:30pm	Results from the world’s largest distributed prospective application of machine learning to small molecule hit discovery	Abraham Heifets (Atomwise)
9:30am-10:15am	12:30pm - 1:15pm	Physics-informed deep learning to accelerate molecular simulation and drug discovery	Tom Miller (Entos AI)
10:15am- 10:25am	1:15pm - 1:25pm	Break
10:25am- 10:35am	1:25pm - 1:35pm	Major Sponsor Presentation	Applied BioMath
10:35am- 11:20am	1:35pm - 2:20pm	Leveraging DNA-encoded library data with machine learning to identify diverse, novel molecular binders to challenging targets	Fio Ruggiu (Insitro)
11:20am- 12:05pm	2:20pm - 3:05pm	Applying Schrodinger computational modeling technology to accelerate discovery of novel inhibitors of D-amino acid oxidase	Wayne Tang & Sathesh Bhat (Schrodinger)
12:05pm-12:20pm	3:05pm - 3:20pm	PANEL DISCUSSION	All speakers

Day 2: November 18

PST	EST	Topic	Presenter
8:30am - 8:45am	11:30am- 11:45am	Welcome Remarks	Kevin McLure (Ermaris Bio)
8:45am - 9:20am	11:45am- 12:20pm	Target Discovery PandaOmics: from hypothesis generation to preclinical candidate nomination	Alex Zhavoronkov (Insilico)
9:20am - 10:05am	12:20pm - 1:05pm	Filling in the gaps: exploring polypharmacology with MatchMaker	Vijay Shahani (Cyclica)
10:05am- 10:15am	1:05pm-1:15pm	Break	-
10:15am-11:00am	1:15pm-2:00pm	Decreasing the risk of immunotoxicity for cancer immunotherapies	Giovanni Mazzocco (Ardigen)
11:00am -11:15am	2:00pm - 2:15pm	PANEL DISCUSSION	All speakers

Other Events of PBSS-San Francisco Bay:

2024-04-26, [In-Person] Oncology Clinical Dose Optimization in Light of FDA Project Optimus

2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies

2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals

2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices

2024-05-30, [Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)

2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices

2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics

2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6

2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies

2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices

2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA